Difference between revisions of "CAR T-cell toxicity management"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "<big>" to "") |
Warner-admin (talk | contribs) m (Text replacement - "</big>" to "") |
||
| Line 1: | Line 1: | ||
| − | '''This page is in process of being created.''' For preparatory regimens for CAR T-cell therapy, please go to [[Chimeric antigen receptor T cells (CAR-T)|this page]]. | + | '''This page is in process of being created.''' For preparatory regimens for CAR T-cell therapy, please go to [[Chimeric antigen receptor T cells (CAR-T)|this page]]. |
{{TOC limit|limit=4}} | {{TOC limit|limit=4}} | ||
Latest revision as of 00:29, 4 July 2024
This page is in process of being created. For preparatory regimens for CAR T-cell therapy, please go to this page.
Grading toxicity
CTCAE
- Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) - Adverse event grading for clinical trials[1]
Evaluation
Management
References
- ↑ Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) - Adverse event grading for clinical trials
- ↑ CTCAE 5x7" small booklet format local backup
- ↑ CTCAE 8.5x11" letter size format local backup